SUBSCRIBE
SUBSCRIBE

Shuttle Pharmaceuticals

IN THE PRESS
Business
Shuttle Pharmaceuticals Holdings, Inc. Announces Appointment of Chris Senanayake, PhD To Board of Directors
May 20, 2021
 · 
2 min read
BioCapital
Shuttle Pharmaceuticals, Inc. Awarded a New Patent for Dual Function HDAC Molecules for HDAC Inhibition and Ataxia Telangiectasia Mutated Activation for Cancer Treatment
November 4, 2020
 · 
3 min read
Business
Shuttle Pharmaceuticals And POLA Pharma Agree To License U.S. Rights To Doranidazole
August 16, 2017
 · 
3 min read
Load More
JOBS